Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

EU Commission writes to CMC in response to industry concerns over device labelling decision

This article was originally published in Clinica

Executive Summary

The European Commission's Directorate General for Health and Consumer Policy (DG Sanco) has written to the Central Management Committee regarding the latter's Decision No 3 on device labelling. This decision, issued last July (www.clinica.co.uk, 18 July 2011), requires the full postal address of manufacturers and authorised representatives to be placed on medical devices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT099094

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel